- call +1-201-465-4211
- email sales@mrinsights.biz
Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss).
Scope of the Report:
This report focuses on the Alzheimer's Disease in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Alzheimer's Disease is expected to grow at a CAGR of roughly 15.5% over the next five years, will reach 6880 million US$ in 2023, from 2900 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Donepezil
Memantine
Rivastigmine
Market Segment by Applications, can be divided into
Early to Moderate Stages
Moderate to Severe Stages
There are 15 Chapters to deeply display the global Alzheimer's Disease market.
Chapter 1, to describe Alzheimer's Disease Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Alzheimer's Disease, with sales, revenue, and price of Alzheimer's Disease, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Alzheimer's Disease, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Alzheimer's Disease market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Alzheimer's Disease sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Alzheimer's Disease Introduction
1.2 Market Analysis by Type
1.2.1 Donepezil
1.2.2 Memantine
1.2.3 Rivastigmine
1.3 Market Analysis by Applications
1.3.1 Early to Moderate Stages
1.3.2 Moderate to Severe Stages
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Alzheimer's Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Alzheimer's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eisai
2.2.1 Business Overview
2.2.2 Alzheimer's Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eisai Alzheimer's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Alzheimer's Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Alzheimer's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Daiichi Sankyo
2.4.1 Business Overview
2.4.2 Alzheimer's Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Daiichi Sankyo Alzheimer's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merz Pharma
2.5.1 Business Overview
2.5.2 Alzheimer's Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merz Pharma Alzheimer's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Alzheimer's Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Alzheimer's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Alzheimer's Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Alzheimer's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Lundbeck
2.8.1 Business Overview
2.8.2 Alzheimer's Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Lundbeck Alzheimer's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Alzheimer's Disease Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Alzheimer's Disease Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alzheimer's Disease Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Alzheimer's Disease Manufacturer Market Share in 2017
3.3.2 Top 6 Alzheimer's Disease Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Alzheimer's Disease Market Analysis by Regions
4.1 Global Alzheimer's Disease Sales, Revenue and Market Share by Regions
4.1.1 Global Alzheimer's Disease Sales and Market Share by Regions (2013-2018)
4.1.2 Global Alzheimer's Disease Revenue and Market Share by Regions (2013-2018)
4.2 North America Alzheimer's Disease Sales and Growth Rate (2013-2018)
4.3 Europe Alzheimer's Disease Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Alzheimer's Disease Sales and Growth Rate (2013-2018)
4.5 South America Alzheimer's Disease Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Alzheimer's Disease Sales and Growth Rate (2013-2018)
5 North America Alzheimer's Disease by Countries
5.1 North America Alzheimer's Disease Sales, Revenue and Market Share by Countries
5.1.1 North America Alzheimer's Disease Sales and Market Share by Countries (2013-2018)
5.1.2 North America Alzheimer's Disease Revenue and Market Share by Countries (2013-2018)
5.2 United States Alzheimer's Disease Sales and Growth Rate (2013-2018)
5.3 Canada Alzheimer's Disease Sales and Growth Rate (2013-2018)
5.4 Mexico Alzheimer's Disease Sales and Growth Rate (2013-2018)
6 Europe Alzheimer's Disease by Countries
6.1 Europe Alzheimer's Disease Sales, Revenue and Market Share by Countries
6.1.1 Europe Alzheimer's Disease Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Alzheimer's Disease Revenue and Market Share by Countries (2013-2018)
6.2 Germany Alzheimer's Disease Sales and Growth Rate (2013-2018)
6.3 UK Alzheimer's Disease Sales and Growth Rate (2013-2018)
6.4 France Alzheimer's Disease Sales and Growth Rate (2013-2018)
6.5 Russia Alzheimer's Disease Sales and Growth Rate (2013-2018)
6.6 Italy Alzheimer's Disease Sales and Growth Rate (2013-2018)
7 Asia-Pacific Alzheimer's Disease by Countries
7.1 Asia-Pacific Alzheimer's Disease Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Alzheimer's Disease Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Alzheimer's Disease Revenue and Market Share by Countries (2013-2018)
7.2 China Alzheimer's Disease Sales and Growth Rate (2013-2018)
7.3 Japan Alzheimer's Disease Sales and Growth Rate (2013-2018)
7.4 Korea Alzheimer's Disease Sales and Growth Rate (2013-2018)
7.5 India Alzheimer's Disease Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Alzheimer's Disease Sales and Growth Rate (2013-2018)
8 South America Alzheimer's Disease by Countries
8.1 South America Alzheimer's Disease Sales, Revenue and Market Share by Countries
8.1.1 South America Alzheimer's Disease Sales and Market Share by Countries (2013-2018)
8.1.2 South America Alzheimer's Disease Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Alzheimer's Disease Sales and Growth Rate (2013-2018)
8.3 Argentina Alzheimer's Disease Sales and Growth Rate (2013-2018)
8.4 Colombia Alzheimer's Disease Sales and Growth Rate (2013-2018)
9 Middle East and Africa Alzheimer's Disease by Countries
9.1 Middle East and Africa Alzheimer's Disease Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Alzheimer's Disease Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Alzheimer's Disease Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Alzheimer's Disease Sales and Growth Rate (2013-2018)
9.3 UAE Alzheimer's Disease Sales and Growth Rate (2013-2018)
9.4 Egypt Alzheimer's Disease Sales and Growth Rate (2013-2018)
9.5 Nigeria Alzheimer's Disease Sales and Growth Rate (2013-2018)
9.6 South Africa Alzheimer's Disease Sales and Growth Rate (2013-2018)
10 Global Alzheimer's Disease Market Segment by Type
10.1 Global Alzheimer's Disease Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Alzheimer's Disease Sales and Market Share by Type (2013-2018)
10.1.2 Global Alzheimer's Disease Revenue and Market Share by Type (2013-2018)
10.2 Donepezil Sales Growth and Price
10.2.1 Global Donepezil Sales Growth (2013-2018)
10.2.2 Global Donepezil Price (2013-2018)
10.3 Memantine Sales Growth and Price
10.3.1 Global Memantine Sales Growth (2013-2018)
10.3.2 Global Memantine Price (2013-2018)
10.4 Rivastigmine Sales Growth and Price
10.4.1 Global Rivastigmine Sales Growth (2013-2018)
10.4.2 Global Rivastigmine Price (2013-2018)
11 Global Alzheimer's Disease Market Segment by Application
11.1 Global Alzheimer's Disease Sales Market Share by Application (2013-2018)
11.2 Early to Moderate Stages Sales Growth (2013-2018)
11.3 Moderate to Severe Stages Sales Growth (2013-2018)
12 Alzheimer's Disease Market Forecast (2018-2023)
12.1 Global Alzheimer's Disease Sales, Revenue and Growth Rate (2018-2023)
12.2 Alzheimer's Disease Market Forecast by Regions (2018-2023)
12.2.1 North America Alzheimer's Disease Market Forecast (2018-2023)
12.2.2 Europe Alzheimer's Disease Market Forecast (2018-2023)
12.2.3 Asia-Pacific Alzheimer's Disease Market Forecast (2018-2023)
12.2.4 South America Alzheimer's Disease Market Forecast (2018-2023)
12.2.5 Middle East and Africa Alzheimer's Disease Market Forecast (2018-2023)
12.3 Alzheimer's Disease Market Forecast by Type (2018-2023)
12.3.1 Global Alzheimer's Disease Sales Forecast by Type (2018-2023)
12.3.2 Global Alzheimer's Disease Market Share Forecast by Type (2018-2023)
12.4 Alzheimer's Disease Market Forecast by Application (2018-2023)
12.4.1 Global Alzheimer's Disease Sales Forecast by Application (2018-2023)
12.4.2 Global Alzheimer's Disease Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Alzheimer's Disease Picture
Table Product Specifications of Alzheimer's Disease
Figure Global Sales Market Share of Alzheimer's Disease by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
